SCHEMBL6535525

SCHEMBL6535525

NC(=O)C1=C(O)C=CC=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15200783 0.79
SCHEMBL2067207 0.71
SCHEMBL29789580 0.62 PYGM (0.38)
SCHEMBL1007936 0.61 LCK (0.37)
Water SCHEMBL28206745 0.60 POLB (0.30)
SCHEMBL3537101 0.60
Hydrogen Sulfide SCHEMBL28207789 0.60 POLB (0.30)
Hydrochloric Acid SCHEMBL27832467 0.60 POLB (0.30)
Hydrochloric Acid SCHEMBL28207816 0.58
Hydrochloric Acid SCHEMBL4701756 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3240779-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF EPILEPSY AND NEUROLOGICAL DISORDERS Cellixbio Private Limited (IN) 2017-11-08 EP disclosed
WO-2016046835-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF EPILEPSY AND NEUROLOGICAL DISORDERS CELLIX BIO PRIVATE LIMITED (IN) 2016-03-31 WO disclosed
US-20040185095-A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release DESITIN ARZNEIMITTEL GMBH (DE) 2004-09-23 US disclosed